Park et al. demonstrated that tumor-derived IL-18 increased immunosuppressive CD56dim CD16dim/− NK cell fraction and induced PD-1 expression in these NK cells, leading to a bad prognosis in TNBC patients [101]. Here, IL18 is linked to neoplasm.